The physicochemical properties and antitumor activity of dacarbazine, its analogs, and the new alkylating agent imidazene are reviewed. It is shown that the activity of dacarbazine is superior to most of its analogs. Imidazene exhibits an advantage over dacarbazine with respect to both stability and activity and can be used for the treatment of malignant melanoma and sarcoma of soft tissues and in combined chemotherapy.
Similar content being viewed by others
References
Sp. Pat. No. 199,822 (1952); Chem. Abstr., 49, 1101i (1955).
USA Pat. No. 2,673,197 (1954); Chem. Abstr., 49, 6303h (1955).
C. P. Dagg, D. A. Karnofsky, C. C. Stock, et al., Proc. Soc. Exp. Biol. Med., 90, 489 – 494 (1955); Chem. Abstr., 50, 4385c (1956).
D. A. Clarke, R. K. Barclay, C. C. Stock, et al., Proc. Soc. Exp. Biol. Med., 90, 484 – 489 (1955); Chem. Abstr., 50, 4384i (1956).
J. H. Burchenal, M. K. Dagg, M. Beyer, et al., Proc. Soc. Exp. Biol. Med., 91, 398 – 401 (1956); Chem. Abstr., 50, 8893h (1956).
Y. F. Shealy, C. A. Krauth, and J. A.Montgomery, J. Org. Chem., 27, No. 6, 2150 – 2154 (1962).
J. A. Montgomery, K. Newson, R. F. Struck, et al., J. Org. Chem., 24(2), 256 – 257 (1959).
Y. F. Shealy, R. F. Struck, L. B. Holum, et al., J. Org. Chem., 26(7), 2396 – 2401 (1961).
Y. F. Shealy, J. Pharm. Sci., 59(11), 1533 – 1558 (1970).
Y. F. Shealy, J. A. Montgomery, and W. R. Laster, Biochem. Pharmacol., 11(7), 674 – 675 (1962).
J. A. Montgomery, Cancer Treat. Rep., 60(2), 125 – 134 (1976).
J. M. Venditti, Cancer Treat. Rep., 60(2), 135 – 140 (1976).
K. Aigner, H. Breithaupt, M. Hundeiker, et al., Anticancer Res., 3(1), 87 – 94 (1983).
R. L. Comis, Cancer Treat. Rep., 60(2), 165 – 176 (1976).
J. K. Horton and M. F. G. Stevens, J. Chem. Soc., Perkin Trans 1, No. 5, 1433 – 1436 (1981); Chem. Abstr., 95, 97666u (1981).
K Hano, A, Akashi, I. Yamamoto, et al., Gann, 56(4), 417 – 420 (1965); Chem. Abstr., 63, 18856g (1965).
K. Hano, A. Akashi, I. Yamamoto, et al., Gann, 59(3), 207 – 216 (1968); Chem. Abstr., 69, 42527g (1968).
Y. F. Shealy, C. A. Krauth, S. J. Clayton, et al., J. Pharm. Sci., 57(9), 1562 – 1568 (1968).
Y. F. Shealy and C. A. Krauth, J. Med. Chem., 9(1), 34–38 (1966).
Jpn. Pat. No. 73 00,828 (1973); Chem. Abstr., 78, 147957m (1973).
V. S. Mokrushin, Z. V. Pushkareva, I. S. Selezneva, et al., Khimioterapiya Opukholei SSSR, 36,3–7 (1982).
N. A. Lesnaya and G. N. Platonova, Khimioterapiya Opukholei SSSR, 36,8–11 (1982).
USA Pat. No. 3,649,613 (1972); Chem. Abstr., 76, 140808p (1972).
J. Heyes, E. J. Catherall, and A. Cockburn, Cancer Chemother. Rep., 57(3), 263 – 268 (1973); Chem. Abstr., 80, 22687h (1974).
GB Pat. No. 1,373,346 (1974); Ref. Zh. Khim., 20 O69P (1975).
GB Pat. No. 1,373,347 (1974); Ref. Zh. Khim., 21 O84P (1975).
V. S. Mokrushin, V. A. Bakulev, and T. E. Zubova, Khimioterapiya Opukholei SSSR, 36, 12 – 14 (1982).
Y. F. Shealy and C. A. O’Dell, J. Pharm. Sci., 64(6), 954 – 956 (1975).
V. S. Mokrushin, V. I. Ofitserov, T. V. Rapakova, et al., Khim. Geterotsikl. Soedin., No. 4, 556 – 559 (1976).
T. A. Pospelova, Yu. M. Shafran, V. S. Mokrushin, et al., Khim.-farm. Zh., 16(5), 543 – 544 (1982).
V. S. Mokrushin, I. S. Selezneva, T. A. Pospelova, et al., Khim.-farm. Zh., 16(3), 303 – 307 (1982).
Hung. Pat. No. 455537 (1971); Otkrytiya Izobr. Prom. Obraztsy Tov. Zhaki, No. 48, 132 (1974).
G. R. Greenberg and E. L. Spilman, J. Biol. Chem., 219, 411 – 422 (1956).
G. R. Greenberg, J. Biol. Chem., 219, 423 – 433 (1956).
R. P. Panzica and L. B. Townsend, J. Org. Chem., 36(12), 1594 – 1596 (1971).
R. A. Earl and L. B. Townsend, J. Med. Chem., 22(11), 1422 – 1423 (1979).
Y. F. Shealy and C. A. O’Dell, J. Med. Chem., 9(5), 733 – 737 (1966).
C. W. Noell and C. C. Cheng, J. Med. Chem., 12(3), 545 – 546 (1969).
Y. F. Shealy and C. A. O’Dell, J. Pharm. Sci., 60(4), 554 – 560 (1971).
USA Pat. No. 4,092,305 (1978); Chem. Abstr., 89, 163904z (1978).
E. A. Shtokareva, V. I. Nifontov, A. B. Dubovik, et al., Khimioterapiya Opukholei SSSR, 36, 21 – 24 (1982).
V. I. Nifontov, V. A. Chernov, Yu. A. Ershova, et al., Khimioterapiya Opukholei SSSR, 44, 18 – 24 (1986).
S. A. Del Prete, L. H. Maurer, J. O. Donnell, et al., Cancer Treat. Rep., 68(11), 1403 – 1405 (1984).
R. W. Carey, J. R. Anderson, M. Green, et al., Cancer Treat. Rep., 70(3), 329 – 331 (1986).
D. A. Vorobiot, R. Sarli, and G. Falkson, Cancer Treat. Rep., 70(7), 927 – 928 (1986).
R. Oratz, J. L.Speyer, M. Green, et al., Cancer Treat. Rep., 71(9), 877 – 878 (1987).
S. Gundersenn, Cancer Treat. Rep., 71(11), 997 – 999 (1987).
R. Uork and A. Foltz, Cancer, 61, 2183 – 2186 (1989).
P. Rumke, U. R. Kleeberg, R. M. MacKie, et al., Melanoma Res., 2(2), 153 – 155 (1992).
E. F. McClay, M. E. McClay, K. A. Albright, et al., Cancer, 72, 1914 – 1918 (1993).
N. M. Bleehan, E. S. Newlands, S. M. Lee, et al., J. Clin. Oncol., 13, 910 – 913 (1995).
C. S. Lattanzi, T. Tosteson, J. Chertoff, et al., Melanoma Res., 5(4), 365 – 369 (1995).
J. J. Rusthoven, I. C. Quirt, N. A. Isckoe, et al., J. Clin. Oncol., 14, 2083 – 2090 (1996).
U. Keilholz, S. Goey, C. Punt, et al., J. Clin. Oncol., 15, 2579 – 2588 (1997).
M. Schultz, A. C. Buzaid, and W. J. Poo, Melanoma Res., 7(2), 147 – 151 (1997).
K. Margolin, P.-Y. Liu, L. Flaherty, et al., J. Clin. Oncol., 16, 664 – 669 (1998).
C. I. Falkson, J. Ibrahim, J. Kirkwood, et al., J. Clin. Oncol., 16, 1743 – 1751 (1998).
R. Hofman and R. Muller, Br. J. Cancer, 78, 1076 – 1080 (1998).
P. Chapman, L. H. Einhom, M. Meyers, et al., J. Clin. Oncol., 17, 2745 – 2751 (1999).
O. Eton, S. Legha, and A. Bedikian, Proc. Am. Soc. Clin. Oncol., 19, 2174 (abstr.) (2000).
M. Lotze and J. Kirkwood, Principles and Practice of Oncology, Lippincott Co., Philadelphia (2001), pp. 2012 – 2069.
J. A. Gottlieb, R. S. Benjamin, and L. H. Baker, Cancer Treat. Rep., 60(2), 199 – 203 (1976).
R. S. Benjamin, L. H. Baker, R. M. O’Bryan, et al., Cancer Treat. Rep., 62(2), 237 – 238 (1978).
R. H. Blum, Cancer, 46, 1522 – 1526 (1980).
B. S. Yap, L. H. Baker, J. G. Sinkovics, et al., Cancer Treat. Rep., 64(1), 93 – 98 (1980).
T. K. Choi, A. Ng, and J. Wong, Cancer Treat. Rep., 69(4), 443 – 444 (1985).
A. D. Elias and H. K. Antman, Cancer Treat. Rep., 70(7), 827 – 833 (1986).
V. Bramwell, I. Quirt, D. Warr, et al., J. Nat. Cancer Inst., 81(19), 1496 – 1499 (1989).
G. Falkson and H. C. Falkson, Cancer Chemother. Rep., 65(1), 31 – 34 (1981).
G. Bonabonna, A. Santoro, V. Bonfante, et al., Cancer Treat. Rep., 66(4), 881 – 887 (1982).
C. W. Young, D. J. Straus, J. Myers, et al., Cancer Treat. Rep., 66(4), 907 – 914 (1982).
B. Lange and A. S. Levine, Cancer Treat. Rep., 66(9), 1699 – 1704 (1982).
V. I. Nifontov, N. R. Bel’skaya, V. A. Chernov, et al., Khim.-farm. Zh., 18(9), 1037 – 1041 (1984).
V. I. Nifontov, N. P. Bel’skaya, V. A. Chernov, et al., Khim.-farm. Zh., 20(3), 277 – 281 (1986).
J. L. Skibba, G. Ramirez, D. D. Beal, et al., Proc. Am. Assoc. Cancer Res., 10(1), 83 – 86 (1969).
J. L. Skibba, D. D. Beal, G. Ramirez, et al., Cancer Res., 30(1), 147 – 150 (1970).
S. K. Carter and M. A. Fridman, Eur. J. Cancer, 8(1), 85–92 (1972).
A. H. Gerulath and T. L. Loo, Biochem. Pharmacol., 21(17), 2335 – 2343 (1972).
A. H. Gerulath, S. C. Barrance, and R. M. Humphrey, Cancer Res., 34(8), 1921 – 1925 (1974).
R. Preussmann and A. von Hodenberg, Biochem. Pharmacol., 19(4), 1505 – 1508 (1970).
F. W. Kruger, R. Preussmann, and N. Niepelt, Biochem. Pharmacol., 20(3), 529 – 533 (1971).
R. C. S. Audette, T. A. Connors, H. G. Mandel, et al., Biochem. Pharmacol., 22(15), 1855 – 1864 (1973).
R. Preussmann, A. von Hodenberg, and H. Hengy, Biochem. Pharmacol., 18(1),1–13 (1969).
T. Giraldi, C. Nisi, and G. Sava, Biochem. Pharmacol., 24(19), 1793 – 1797 (1975).
G. Abel, J. A.Connors, and T. Giraldi, Cancer Lett., 3, 259 – 264 (1977).
G. Sava, T. Giraldi, L. Lassiani, et al., Cancer Treat. Rep., 63(1), 93 – 98 (1979).
H. Druckrey, S. Ivankovic, and R. Preussmann, Naturwissenschaften, 54(7), 171 (1967); Chem. Abstr., 67, 9477b (1967).
E. C. Miller and J. A. Miller, Pharm. Rev., 18, 805 (1966).
H. Druckrey, S. Ivancovic, R. Preussmann, et al., Experientia, 23(12), 1042 – 1043 (1967); Chem. Abstr., 68, 20412t (1968).
C. S. Rondenstvedt and S. D. Davis, J. Org. Chem., 22(2), 200 – 203 (1957).
GB Pat. No. 941489 (1963); Chem. Abstr., 60, 6788a (1964).
USA Pat. No. 3162571 (1964); Chem. Abstr., 62, 14568f (1965).
Z. B. Papanastassiow, B. J. Bruni, E. White, et al., J. Med. Chem., 9(5), 725 – 729 (1966).
SAR Pat. No. 69 03.874 (1969); Chem. Abstr., 73, 43839e (1970).
SAR Pat. No. 69 04.895 (1970); Chem. Abstr., 73, 55823h (1970).
Y. F. Shealy, C. A. O’Dell, J. D. Clayton, et al., J. Pharm. Sci., 60(9), 1426 – 1428 (1971).
Y. T. Lin and T. L. Loo, J. Med. Chem., 15(2), 201 – 203 (1972).
T. A. Connors, P. M. Goddard, K. M. Walter, et al., Biochem. Pharmacol., 25(3), 241 – 246 (1976).
A. I. Kravchenko, V. A. Chernov, V. G. Voronin, et al., Khim.-farm. Zh., 10(11), 72 – 75 (1976).
T. Giraldi, C. Nisi, T. A. Connors, et al., J. Med. Chem., 20(6), 850 – 853 (1977).
T. Giraldi, P. J. Houghton, D. M. Taylor, et al., Cancer Treat. Rep., 62(5), 721 – 725 (1978).
M. Matrka, V. Rambousec, L. Drzkova, et al., Cesk. Farm., 27(7), 299 – 303 (1978); Chem. Abstr., 90, 174739w (1979).
G. F. Kolar and R. Carubelli, Cancer Lett., 7(4), 209 – 214 (1979); Chem. Abstr., 92, 33653t (1980).
T. Giraldi, P. M. Goddard, C. Nisi, et al., J. Pharm. Sci., 69(1), 97 – 98 (1980).
D. E. V. Wilman and P. M. Goddard, J. Med. Chem., 23(9), 1052 – 1054 (1980).
G. Sava, T. Giraldi, G. Zupi, et al., Invasion Metastasis, 4(3), 171 – 178 (1984); Chem. Abstr., 101, 183564h (1984).
G. Zupi, A. Corsi, A. Sacchi, et al., Invasion Metastasis, 4(3), 179 – 188 (1984); Chem. Abstr., 101, 183565j (1984).
D.-C. Zhang, Z.-H. Fei, T.-Z. Zhang, Y.-Q. Zhang and K.-B. Yu, Acta Crystallogr. Sect. C: Cryst. Struct. Commun., 55, 102 – 104 (1999); Chem. Abstr., 130, 146500n (1999).
V. Kettmann, J. Lokaj, J. Korisek, et al., Acta Crystallogr. Sect. C: Cryst. Struct. Commun., 60, 143 – 145 (2004).
G. Diadone, B. Maggio, D. Raffa, et al., Il Farmaco, 59(5), 413 – 417 (2004).
M. J. Wanner, M. Koch, and G.-I. Komen, J. Med. Chem., 47(27), 6875 – 6883 (2004).
M. Wolf, U. Bauder-Wust, A. Mohammed, et al., Melanoma Res., 14(5), 353 – 360 (2004).
P. Farina, E. Benfenati, R. Reginato, et al., Biomed. Spectrom., 10(8), 485 – 488 (2005).
J. Prikril, M. Cerny, H. Belohlavova, et al., Dyes Pigm., 72(3), 392 – 402 (2007).
G. M. Stepanyan, F. G. Arsenyan, M. A. Iradyan, et al., Khimioterapiya Opukholei SSSR, 36, 170 – 174 (1982).
M. A. Iradyan, N. S. Iradyan, A. A. Ovagimyan, et al., Khim.-farm. Zh., 18(7), 807 – 811 (1984).
M. A. Iradyan, S. A. Sargisyan, A. P. Engoyan, et al., Arm. Khim. Zh., 32(6), 475 – 480 (1979).
M. A. Iradyan, N. S. Iradyan, G. M. Stepanyan, et al., Khim.-farm. Zh., 35(4),7–9 (2001).
G. M. Stepanyan, F. G. Arsenyan, B. T. Garibdzhanyan, et al., Khimioterapiya Opukholei SSSR, 47, 52 – 57 (1987).
M. A. Iradyan, N. S. Iradyan, V. S. Mirzoyan, et al., Khimioterapiya Opukholei SSSR, 49, 62 – 67 (1987).
M. A. Iradyan, N. S. Iradyan, G. M. Stepanyan, et al., RF Pat. No. 1074091 (1993).
V. M. Zemskov, M. Yu. Lidak, A. M. Zemskov, et al., Low-Molecular-Weight RNA. Production, Hydrolysis, and Application in Medicine [in Russian], Zinatne, Riga (1985).
I. I. Epstein, Clin. Oncol., 8(12), 2062 – 2084 (1990).
R. Kumar and I. W. Lown, Mini Rev. Med. Chem., 3(4), 323 – 339 (2003).
Yu. S. Babayan, N. V. Khudaverdyan, A. E. Sngryan, et al., Biofizika, 42(1), 125 – 129 (1997).
B. T. Garibjanian, N. V. Khudaverdian, and J. T. Garibian, Eighth Inter. Congress on Anti-Cancer Treatment, Paris (1998), p. 249.
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 44, No. 4, pp. 11 – 18, April, 2010.
Deceased
Rights and permissions
About this article
Cite this article
Iradyan, M.A., Iradyan, N.S., Stepanyan, G.M. et al. Antitumor activity of imidazole derivatives: dacarbazine and the new alkylating agent imidazene (Review). Pharm Chem J 44, 175–182 (2010). https://doi.org/10.1007/s11094-010-0425-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-010-0425-6